Atlas Trials

Expanded Access Protocol Using 131I-MIBG Therapy +/- Vorinostat for Refractory Neuroblastoma, Pheochromocytoma, or Paraganglioma

Clinical trial NCT01838187 · NO_LONGER_AVAILABLE

Trial details

NCT number
NCT01838187
Sponsor
Children's Hospital Medical Center, Cincinnati
Status
NO_LONGER_AVAILABLE
Study type
EXPANDED_ACCESS
NeuroblastomaPheochromocytomaParaganglioma

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.